A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Anileridine
Naftopidil
The risk or severity of bleeding can be increased when Antipyrine is combined with Naftopidil.
Anileridine
Trapidil
The risk or severity of bleeding can be increased when Antipyrine is combined with Trapidil.
Anileridine
Icosapent ethyl
The risk or severity of bleeding can be increased when Antipyrine is combined with Icosapent ethyl.
Anileridine
Tranilast
The risk or severity of bleeding can be increased when Antipyrine is combined with Tranilast.
Anileridine
Caplacizumab
The risk or severity of bleeding can be increased when Antipyrine is combined with Caplacizumab.
Anileridine
Andrographolide
The risk or severity of bleeding can be increased when Antipyrine is combined with Andrographolide.
Anileridine
Ibudilast
The risk or severity of bleeding can be increased when Antipyrine is combined with Ibudilast.
Anileridine
Tesmilifene
The risk or severity of bleeding can be increased when Antipyrine is combined with Tesmilifene.
Anileridine
Resveratrol
The risk or severity of bleeding can be increased when Antipyrine is combined with Resveratrol.
Anileridine
Sevoflurane
The risk or severity of bleeding can be increased when Antipyrine is combined with Sevoflurane.
Anileridine
Ridogrel
The risk or severity of bleeding can be increased when Antipyrine is combined with Ridogrel.
Anileridine
Testosterone undecanoate
Testosterone undecanoate may increase the hypertensive activities of Antipyrine.
Anileridine
Propacetamol
The risk or severity of adverse effects can be increased when Propacetamol is combined with Antipyrine.
Anileridine
Solriamfetol
The risk or severity of hypertension can be increased when Solriamfetol is combined with Antipyrine.
Anileridine
Polymyxin B
The risk or severity of adverse effects can be increased when Antipyrine is combined with Polymyxin B.
Anileridine
Esketamine
The risk or severity of hypertension can be increased when Esketamine is combined with Antipyrine.
Anileridine
Macimorelin
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Antipyrine.
Anileridine
Emapalumab
The metabolism of Antipyrine can be increased when combined with Emapalumab.
Anileridine
Siltuximab
The metabolism of Antipyrine can be increased when combined with Siltuximab.
Anileridine
Secukinumab
The metabolism of Antipyrine can be increased when combined with Secukinumab.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3